Colorado Nurse Loses DEA License: No Hearing, No Mercy
Published Date: 7/16/2025
Notice
Summary
Diana Clouthier, a nurse practitioner from Colorado, lost her DEA registration because she no longer has permission to handle controlled substances in her state. She didn’t ask for a hearing after being notified, so the DEA moved forward and officially revoked her registration. This means she can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for N.P.
The DEA revoked Diana Clouthier's Certificate of Registration No. MC5780639 and denied any pending applications to renew, modify, or obtain additional registration in Colorado. The Agency found her Colorado nursing licenses were suspended on October 21, 2024, and the Order takes effect August 15, 2025.
State License Loss Triggers DEA Revocation
Under 21 U.S.C. 824(a)(3) and related provisions cited in this Order, if a practitioner's State license or registration is suspended or revoked so that they are no longer authorized to handle controlled substances in that State, the DEA may revoke the practitioner's DEA registration. The Order cites this rule as the basis for revoking the registrant's DEA registration after Colorado suspended her licenses.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-11909 — Importer of Controlled Substances Application: Cerilliant Corporation
Cerilliant Corporation wants to become an official importer of certain controlled substances, including some drugs that need strict government oversight. People and companies involved with these substances can share their thoughts or ask for a hearing by July 15, 2026. This move could affect how these drugs enter the U.S. and might impact businesses handling them.
2026-11572 — Ashley Vermillion, N.P.; Decision and Order
Ashley Vermillion, a nurse practitioner from Maine, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her registration. This means she can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-11416 — Importer of Controlled Substances Application: CalCog Inc.
CalCog Inc. wants to become an official importer of some powerful controlled substances like LSD and 5-MeO-DMT. People and companies involved with these drugs have until July 8, 2026, to share their thoughts or ask for a hearing. This move could shake up the import scene, but no costs or changes happen until the DEA decides.
2026-10380 — Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
The DEA wants to put diphenidine, a drug, into Schedule I, which means it will be treated like the most tightly controlled substances. This change affects anyone who makes, sells, studies, or owns diphenidine, adding strict rules and penalties. You’ve got until June 25, 2026, to share your thoughts before the new rules might kick in.
Previous / Next Documents
Previous: 2025-13352 — New Hampshire Department of Environmental Services; Notice of Application for Surrender of Exemption Accepted for Filing, Soliciting Comments, Motions To Intervene, and Protests
The New Hampshire Department of Environmental Services wants to give up a special exemption for the Squam Lake Dam Hydroelectric Project. This change could affect local energy rules and lets the public share their thoughts by August 12, 2025. If you care about the environment or energy in Grafton County, now’s the time to speak up!
Next: 2025-13365 — Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Unmanned Aircraft Systems (UAS) and Their Parts and Components
The government is checking if importing drones and their parts could affect our national security. If you make, sell, or use drones, now’s your chance to share your thoughts before any new rules are made. Comments are open soon, so don’t miss out on helping shape the future of drone imports and trade!